TFMBOX is a putative serotonergic psychedelic of the phenethylamine and benzoxepin ("BOX") families. It is the cyclized phenethylamine analogue of DOTFM and 2C-TFM in which the α carbon has been connected to the 2-methoxy group via an ethyl chain to form a benzoxepin ring system.
Interactions
Pharmacology
Pharmacodynamics The drug was assessed at and showed affinity for the serotonin 5-HT2A and 5-HT1A receptors, with Ki values of 340 nM and 1,300 nM, respectively. Its affinity for the serotonin 5-HT2A receptor was about 15-fold lower than that of DOB and DOI, whereas its affinity for the serotonin 5-HT1A receptor was the same as that of DOI and was about half that of DOB. TFMBOX also very weakly inhibited the reuptake of serotonin (IC50Tooltip half-maximal inhibitory concentration = 9,900 nM), but did not affect dopamine or norepinephrine reuptake (IC50 = >50,000–100,000 nM). The drug fully substituted for LSD in rodent drug discrimination tests, albeit with about one-third of the potency of DOB and 2C-B.
Chemistry
Analogues
Other "BOX" drugs that have been assessed include BOX (the cyclized analogue of 2C-H and DOH), BBOX (the cyclized analogue of 2C-B and DOB), and IBOX (the cyclized analogue of 2C-I and DOI). However, BBOX and IBOX only partially substituted for LSD in drug discrimination tests.
History TFMBOX was first described in the scientific literature by Nicholas Cozzi, a student of David E. Nichols, by 1994.
See also Cyclized phenethylamine 2CB-Ind 2CB7 6-AB CT-5126 Lorcaserin TCB-2
References
External links TFMBOX - Isomer Design POD 81: Dr. Carl Hart and Dr. Nicholas Cozzi at the MAPS conference - Hamilton Morris - The Hamilton Morris Podcast POD 69: The Alchemist with Dr. Tarik Peterson - Hamilton Morris - The Hamilton Morris Podcast POD 99: February Q&A (finally) - Hamilton Morris - The Hamilton Morris Podcast





